Experimental injection offers hope for Tough-to-Treat skin cancer
NCT ID NCT07227870
Summary
This study is testing a new injection treatment for people with advanced basal cell carcinoma, a type of skin cancer, who haven't responded well to or can't tolerate standard treatments. The treatment involves weekly injections directly into the tumors for up to four weeks, with the possibility of another round if needed. Researchers will monitor how well the treatment works and its safety over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, Florida, 33612, United States
Contact
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact
-
Winship Cancer Institute, Emory University
Atlanta, Georgia, 30322, United States
Contact
Conditions
Explore the condition pages connected to this study.